The role of the L-arginine-nitric oxide pathway in preeclampsia

Therapeutic Advances in Cardiovascular Disease

Volumn 2, Issue 4, 2008, Pages 261-275

  López Jaramillo, Patricio ^a   Arenas, William D ^b   García, Ronald G ^b   Rincon, Melvin Y ^b   López, Marcos ^c  

^a UNIVERSIDAD DE SANTANDER   (Colombia)

^b Neurovascular Science Group   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Endothelium; Infection; Inflammation; Nitric Oxide; Preeclampsia

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ASCORBIC ACID; CALCIUM; CONJUGATED LINOLEIC ACID; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRITE; PLACEBO; SUPEROXIDE;

CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CLINICAL FEATURE; CLINICAL TRIAL; DIET SUPPLEMENTATION; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; EVIDENCE BASED MEDICINE; GENETIC POLYMORPHISM; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; INFECTION; INFLAMMATION; LEUKOCYTE ADHERENCE; NONHUMAN; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION;

ARGININE; BLOOD VOLUME; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY;

EID: 68749085164     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944708092277     Document Type: Review

References (127)

1. Alexander, B.T., Llinas, M.T., Kruckeberg, W.C. and Granger, J.P. (2004)L-Arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure. Hypertension 43: 832-836.
2. Aydin, S., Benian, A., Madazli, R., Uludag, S., Uzun, H. and Kaya, S. (2004)Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia. Eur J Obstet Gynecol Reprod Biol 113: 21-25.
3. Baksu, B., Davas, I., Baksu, A., Akyol, A. and Gulbaba, G. (2005)Plasma nitric oxide, endothelin-1 and urinary nitric oxide and cyclic guanosine monophosphate levels in hypertensive pregnant women. Int J Gynaecol Obstet 90: 112-117.
4. Baylis, C., Beinder, E., Suto, T. and August, P. (1998)Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy. Semin Nephrol 18: 208-230.
5. Begum, S., Yamasaki, M. and Mochizuki, M. (1996)Urinary levels of nitric oxide metabolites in normal pregnancy and preeclampsia. J Obstet Gynaecol Res 22: 551-559.
6. Berkowitz, D.E., White, R., Li, D., Minhas, K.M., Cernetich, A., Kim, S.et al.Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108: 2000-2006.
7. Biri, A., Bozkurt, N., Gunaydin, G., Korucuoglu, U., Durak, I. and Kavutcu, M. (2007)Antioxidant enzyme activities and lipid peroxidation in preeclampsia. Int J Gynaecol Obstet 96: 196-197.
8. Brockelsby, J., Hayman, R., Ahmed, A., Warren, A., Johnson, I. and Baker, P. (1999)VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia. Lab Invest 79: 1101-1111.
9. Celik, O., Hascalik, S. and Turkoz, Y. (2003)cFN and NO levels as indexes of endothelial damage in pre-eclampsia. Int J Gynaecol Obstet 81: 51-52.
10. Celik, O., Hascalik, S., Turkoz, Y., Hascalik, M. and Gokdeniz, R. (2003)Cerebrospinal fluid nitric oxide level changes in preeclampsia. Eur J Obstet Gynecol Reprod Biol 111: 141-145.
11. Chamy, V.M., Lepe, J., Catalan, A., Retamal, D., Escobar, J.A. and Madrid, E.M. (2006)Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol Res 39: 229-236.
12. Chesley, L.C. (1972)Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol 112: 440-450.
13. Cockell, A.P. and Poston, L. (1997)Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 30: 247-251.
14. Conrad, K.P., Kerchner, L.J. and Mosher, M.D. (1999)Plasma and 24-h NO(x) and cGMP during normal pregnancy and preeclampsia in women on a reduced NO(x) diet. Am J Physiol 277: F48-F57.
15. D'Anna, R., Baviera, G., Corrado, F., Crisafulli, A., Ientile, R., Buemi, M.et al. (2004)Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction. BJOG 111: 1046-1050.
16. Davidge, S.T., Stranko, C.P. and Roberts, J.M. (1996)Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 174: 1008-1013.
17. Dechend, R., Homuth, V., Wallukat, G., Kreuzer, J., Park, J.K., Theuer, J.et al.AT (1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 101: 2382-2387.
18. Deng, A., Engels, K. and Baylis, C. (1996)Impact of nitric oxide deficiency on blood pressure and glomerular hemodynamic adaptations to pregnancy in the rat. Kidney Int 50: 1132-1138.
19. Diedrich, F., Renner, A., Rath, W., Kuhn, W. and Wieland, E. (2001)Lipid hydroperoxides and free radical scavenging enzyme activities in preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: no evidence for circulating primary products of lipid peroxidation. Am J Obstet Gynecol 185: 166-172.
20. Diejomaoh, F.M., Omu, A.E., Al Busiri, N., Taher, S., Al Othman, S., Fatinikun, T.et al. (2004) Nitric oxide production is not altered in preeclampsia. Arch Gynecol Obstet 269: 237-243.
21. Dorup, I., Skajaa, K. and Sorensen, K.E. (1999)Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. Am J Physiol 276: H821-H825.
22. Egerman, R.S., Andersen, R.N., Manejwala, F.M. and Sibai, B.M. (1999)Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women. Am J Obstet Gynecol 181: 921-923.
23. Ellis, J., Wennerholm, U.B., Bengtsson, A., Lilja, H., Pettersson, A., Sultan, B.et al. (2001)Levels of dimethylarginines and cytokines in mild and severe preeclampsia. Acta Obstet Gynecol Scand 80: 602-608.
24. Facchinetti, F., Longo, M., Piccinini, F., Neri, I. and Volpe, A. (1999)L-Arginine infusion reduces blood pressure in preeclamptic women through nitric oxide release. J Soc Gynecol Invest 6: 202-207.
25. Facchinetti, F., Saade, G.R., Neri, I., Pizzi, C., Longo, M. and Volpe, A. (2007)L-arginine supplementation in patients with gestational hypertension: a pilot study. Hypertens Preg 26: 121-130.
26. Felix, C., Lopez, A., Delgado, F., Amores, E., Narvaez, M. and Lopez-Jaramillo, P. (1991)Vascular prostacyclin production in Andean women with pregnancy-induced hypertension. Braz J Med Biol Res 24: 59-62.
27. Fickling, S.A., Williams, D., Vallance, P., Nussey, S.S. and Whitley, G.S. (1993)Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 342: 242-243.
28. Garcia, R.G., Celedon, J., Sierra-Laguado, J., Alarcon, M.A., Luengas, C., Silva, F.et al. (2007)Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens 20: 98-103.
29. Gilbert, J.S., Ryan, M.J., La Marca, B.B., Sedeek, M.H., Murphy, S.R. and Granger, J.P. (2007)Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 294: H541-H550.
30. Hata, T., Hashimoto, M., Kanenishi, K., Akiyama, M., Yanagihara, T. and Masumura, S. (1999)Maternal circulating nitrite levels are decreased in both normal normotensive pregnancies and pregnancies with preeclampsia. Gynecol Obstet Invest 48: 93-97.
31. Heilmann, L. (1987)Blood rheology and pregnancy. Baillieres Clin Haematol 1: 777-799.
32. Herrera, J.A., Arevalo-Herrera, M., Shahabuddin, A.K., Ersheng, G., Herrera, S., Garcia, R.G.et al. (2006)Calcium and conjugated linoleic acid reduces pregnancy-induced hypertension and decreases intracellular calcium in lymphocytes. Am J Hypertens 19: 381-387.
33. Herrera, J.A., Chaudhuri, G. and Lopez-Jaramillo, P. (2001)Is infection a major risk factor for preeclampsia ? Med Hypotheses 57: 393-397.
34. Herrera, J.A., Parra, B., Herrera, E., Botero, J.E., Arce, R.M., Contreras, A.et al. (2007)Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia. J Hypertens 25: 1459-1464.
35. Herrera, J.A., Shahabuddin, A.K., Ersheng, G., Wei, Y., Garcia, R.G. and Lopez-Jaramillo, P. (2005)Calcium plus linoleic acid therapy for pregnancy-induced hypertension. Int J Gynaecol Obstet 91: 221-227.
36. Hill, J.A., Devoe, L.D. and Bryans Jr, C.I. (1986)Frequency of asymptomatic bacteriuria in preeclampsia. Obstet Gynecol 67: 529-532.
37. Holden, D.P., Fickling, S.A., Whitley, G.S. and Nussey, S.S. (1998)Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol 178: 551-556.
38. Joffe, G.M., Esterlitz, J.R., Levine, R.J., Clemens, J.D., Ewell, M.G., Sibai, B.M.et al. (1998)The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 179: 1032-1037.
39. Kharb, S. (2000)Low whole blood glutathione levels in pregnancies complicated by preeclampsia and diabetes. Clin Chim Acta 294: 179-183.
40. Kovasc, A.G., Makary, A., Peto, J. and Steinmetz, G. (1994)Deficiency of cGMP level in placental circulation in pregnancy-induced hypertensive disorders: possibility of decreased endothelium-derived relaxing factor. Hypertens Pregn 13: 163-169.
41. Kuzkaya, N., Weissmann, N., Harrison, D.G. and Dikalov, S. (2003)Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem 278: 22546-22554.
42. Lees, M.M., Taylor, S.H., Scott, D.B. and Kerr, M.G. (1974)A study of cardiac output at rest throughout pregnancy. J Obstet Gynaecol Br Commonw 74: 319-328.
43. Levine, R.J., Maynard, S.E., Quian, C., Lim, K.H., England, L.J., Yu, K.F.et al. (2004)Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350: 672-683.
44. Li, H., Meininger, C.J., Hawker Jr, J.R., Haynes, T.E., Kepka-Lenhart, D., Mistry, S.K.et al. (2001)Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab 280: E75-E82
45. Li, N. and Karin, M. (1999)Is NF-kappaB the sensor of oxidative stress ? FASEB J 13: 1137-1143.
46. Lopez-Jaramillo, P. (1996)Prevention of preeclampsia with calcium supplementation and its relation with the L-arginine:nitric oxide pathway. Braz J Med Biol Res 29: 731-741.
47. López-Jaramillo, P. (2000)Calcium, nitric oxide and preclampsia. Sem Perinatol 24: 33-36.
48. Lopez-Jaramillo, P., Casas, J.P. and Serrano, N. (2001)Preeclampsia: from epidemiological observations to molecular mechanisms. Braz J Med Biol Res 34: 1227-1235.
49. Lopez-Jaramillo, P., Delgado, F., Jacome, P., Teran, E., Ruano, C. and Rivera, J. (1997)Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstet Gynecol 90: 162-167.
50. Lopez-Jaramillo, P., García, R. and Silva, F. (2005) Asymetric Dimethylarginine (ADMA): patophysiological reality or biological curiosity. In Hernandez-Hernandez, R., Armas-Hernandez, M.(ed.), Current advances in hypertension, Editorial Monduzzi : Bologna, pp. 57-62.
51. Lopez-Jaramillo, P., Garcia, R.G. and Lopez, M. (2005)Preventing pregnancy-induced hypertension: are there regional differences for this global problem ? J Hypertens 23: 1121-1129.
52. Lopez-Jaramillo, P., Gonzalez, M.C., Palmer, R.M. and Moncada, S. (1990)The crucial role of physiological Ca2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone. Br J Pharmacol 101: 489-493.
53. Lopez-Jaramillo, P., Narvaez, M., Calle, A., Rivera, J., Jacome, P., Ruano, C.et al. (1996)Cyclic guanosine 3',5' monophosphate concentrations in pre-eclampsia: effects of hydralazine. Br J Obstet Gynaecol 103: 33-38.
54. Lopez-Jaramillo, P., Narvaez, M., Felix, C. and Lopez, A. (1990)Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet 335:293.
55. Lopez-Jaramillo, P., Narvaez, M., Felix, C., Sosa, C., Calle, A., Nava, E.et al. (1992) Decreased nitric oxide synthesis in Andean Ecuadorian women with pregnancy-induced hypertension. Biology of nitric oxide, Portland Press: London, p. 376.
56. Lopez-Jaramillo, P., Narvaez, M., Weigel, R.M. and Yepez, R. (1989)Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol 96: 648-655.
57. Lopez-Jaramillo, P., Teran, E. and Moncada, S. (1995)Calcium supplementation prevents pregnancy-induced hypertension by increasing the production of vascular nitric oxide. Med Hypotheses 45: 68-72.
58. López-Jaramillo, P., Teran, E., Ringgvist, A., Moya, W., Rivera, J. and Berrazueta, J.R. (1998) Oxidised low-density lipoproteins and nitric oxide during normal pregnancy and preeclampsia. In Moncada, S., Toda, N., Maeda, H., Higgs, E.A.(ed.), Biology of nitric oxide, Part 6. Portland Press: London, p. 322.
59. Lowe, D.T. (2000)Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 4: 441-458.
60. Lund, C.J. and Donovan, J.C. (1967)Blood volume during pregnancy. Significance of plasma and red cell volumes. Am J Obstet Gynecol 98: 394-403.
61. Maas, R., Boger, R.H., Schwedhelm, E., Casas, J.P., Lopez-Jaramillo, P., Serrano, N.et al. (2004)Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia. JAMA 291: 823-824.
62. Madazli, R., Benian, A., Gumustas, K., Uzun, H., Ocak, V. and Aksu, F. (1999)Lipid peroxidation and antioxidants in preeclampsia. Eur J Obstet Gynecol Reprod Biol 85: 205-208.
63. Makkonen, N., Heinonen, S., Hongisto, T., Penttila, I. and Kirkinen, P. (2002)Normalization of vasoactive changes in preeclampsia precedes clinical recovery. Hypertens Pregnancy 21: 51-64.
64. Many, A., Hubel, C.A., Fisher, S.J., Roberts, J.M. and Zhou, Y. (2000)Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 156: 321-331.
65. Maynard, S.E., Min, J.Y., Merchan, J., Lim, K.H., Li, J., Mondal, S.et al. (2003)Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658.
66. McCord, N., Ayuk, P., McMahon, M., Boyd, R.C., Sargent, I. and Redman, C. (2006)System y+ arginine transport and NO production in peripheral blood mononuclear cells in pregnancy and preeclampsia. Hypertension 47: 109-115.
67. Metcalfe, J. and Ueland, K. (1974)Maternal cardiovascular adjustments to pregnancy. Prog Cardiovasc Dis 16: 363-374.
68. Moncada, S., Higgs, Hodson H.F., Knowles, R.G., López-Jaramillo, P., McCall, T.et al. (1991)The L-arginine: nitric oxide pathway. Journal of Cardiovascular Pharmacology 17: s1-s9.
69. Moutquin, J.M., Rainville, C., Giroux, L., Raynauld, P., Amyot, G., Bilodeau, R.et al. (1985)A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am J Obstet Gynecol 151: 191-196.
70. Mutlu-Turkoglu, U., Aykac-Toker, G., Ibrahimoglu, L., Ademoglu, E. and Uysal, M. (1999)Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery. Gynecol Obstet Invest 48: 247-250.
71. Myatt, L. and Cui, X. (2004)Oxidative stress in the placenta. Histochem Cell Biol 122: 369-382.
72. Myatt, L., Rosenfield, R.B., Eis, A.L.W., Brockman, D.E., Greer, I. and Lyall, F. (1996)Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 28: 488-493.
73. Neri, I., Marietta, M., Piccinini, F., Volpe, A. and Facchinetti, F. (1998)The L-arginine-nitric oxide system regulates platelet aggregation in pregnancy. J Soc Gynecol Invest 5: 192-196.
74. Neri, I., Mazza, V., Galassi, M.C., Volpe, A. and Facchinetti, F. (1996) Effects of L-arginine
75. on utero-placental circulation in growth-retarded fetuses. Acta Obstet Gynecol Scand 75: 208-212.
76. Neri, I., Piccinini, F., Marietta, M., Facchinetti, F. and Volpe, A. (2000)Platelet responsiveness to L-arginine in hypertensive disorders of pregnancy. Hypertens Pregnancy 19: 323-330.
77. Nishikawa, S., Miyamoto, A., Yamamoto, H., Ohshika, H. and Kudo R. (2000)The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia. Life Sci 67: 1447-1454.
78. Noris, M., Perico, N. and Remuzzi, G. (2005)Mechanisms of disease: pre-eclampsia. Nat Clin Pract Nephrol 1: 98-114.
79. Noris, M., Todeschini, M., Cassis, P., Pasta, F., Cappellini, A., Bonazzola, S.et al. (2004)L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 43: 614-622.
80. Norris, L.A., Higgins, J.R., Darling, M.R., Walshe, J.J. and Bonnar, J. (1999)Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia. Obstet Gynecol 93: 958-963.
81. Pasaoglu, H., Bulduk, G., Ogus, E., Pasaoglu, A. and Onalan, G. (2004)Nitric oxide, lipid peroxides, and uric acid levels in pre-eclampsia and eclampsia. Tohoku J Exp Med 202: 87-92.
82. Radi, R., Beckman, J.S., Bush, K.M. and Freeman, B.A. (1991)Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288: 481-487.
83. Ranta, V., Viinikka, L., Halmesmaki, E. and Ylikorkala, O. (1999)Nitric oxide production with preeclampsia. Obstet Gynecol 93: 442-445.
84. Ronson, R.S., Nakamura, M. and Vinten-Johansen, J. (1999)The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res 44: 47-59.
85. Rumbold, A., Duley, L., Crowther, C. and Haslam, R. (2007) Antioxidants for preventing pre-eclampsia (Cochrane Review). In The Cochrane Library, Issue 4, Update Software:Oxford.
86. Saarelainen, H., Laitinen, T., Raitakari, O.T., Juonala, M., Heiskanen, N., Lyyra-Laitinen, T.et al.
87. ( 2006)Pregnancy-related hyperlipidemia and endothelial function in healthy women. Circ J 70: 768-772.
88. Sagol, S., Ozkinay, E. and Ozsener, S. (1999)Impaired antioxidant activity in women with pre-eclampsia. Int J Gynaecol Obstet 64: 121-127.
89. Sankaraligam, S., Arenas, I.A., Lalu, M.M. and Davidge, S.T. (2006)Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 8: 1-20.
90. Savvidou, M.D., Hingorani, A.D., Tsikas, D., Frolich, J.C., Vallance, P. and Nicolaides, K.H. (2003)Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361: 1511-1517.
91. Savvidou, M.D., Kametas, N.A., Donald, A.E. and Nicolaides, K.H. (2000)Non-invasive assessment of endothelial function in normal pregnancy. Ultrasound Obstet Gynecol 15: 502-507.
92. Schiessl, B., Strasburger, C., Bidlingmaier, M., Mylonas, I., Jeschke, U., Kainer, F.et al. (2006)Plasma- and urine concentrations of nitrite / nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet 274: 150-154.
93. Schneider, F., Lutun, P., Baldauf, J.J., Quirin, L., Dreyfus, M., Ritter, J.et al. (1996)Plasma cyclic GMP concentrations and their relationship with changes of blood pressure levels in pre-eclampsia. Acta Obstet Gynecol Scand 75: 40-44.
94. Seligman, S.P., Buyon, J.P., Clancy, R.M., Young, B.K. and Abramson, S.B. (1994)The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 171: 944-948.
95. Serdar, Z., Gur, E., Develioglu, O., Colakogullari, M. and Dirican, M. (2002)Placental and decidual lipid peroxidation and antioxidant defenses in preeclampsia. Lipid peroxidation in preeclampsia. Pathophysiology 9: 21-25.
96. Serrano, N.C., Casas, J.P., Diaz, L.A., Paez, C., Mesa, C.M., Cifuentes, R.et al. (2004)Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study. Hypertension 44: 702-707.
97. Shaamash, A.H., Elsnosy, E.D., Makhlouf, A.M., Zakhari, M.M., Ibrahim, O.A. and EL dien, H.M. (2000)Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynaecol Obstet 68: 207-214.
98. Sharma, J.B., Sharma, A., Bahadur, A., Vimala, N., Satyam, A. and Mittal, S. (2006)Oxidative stress markers and antioxidant levels in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 94: 23-27.
99. Sierra-Laguado, J., Garcia, R.G. and Lopez-Jaramillo, P. (2006)Flow-mediated dilatation of the brachial artery in pregnancy. Int J Gynaecol Obstet 93: 60-61.
100. Sierra-Laguado, J., Garcia, R.G., Celedon, J., Arenas-Mantilla, M., Pradilla, L.P., Camacho, P.A.et al. (2007)Determination of insulin resistance using the homeostatic model assessment (HOMA) and its relation with the risk of developing pregnancy-induced hypertension. Am J Hypertens 20: 437-442.
101. Silver, R.K., Kupferminc, M.J., Russell, T.L., Adler, L., Mullen, T.A. and Caplan, M.S. (1996)Evaluation of nitric oxide as a mediator of severe preeclampsia. Am J Obstet Gynecol 175: 1013-1017.
102. Sladek, S.M., Magness, R.R. and Conrad, K.P. (1997)Nitric oxide and pregnancy. Am J Physiol 272: R441-R463.
103. Slaghekke, F., Dekker, G. and Jeffries, B. (2006)Endogenous inhibitors of nitric oxide and preeclampsia: a review. J Matern Fetal Neonatal Med 19: 447-452.
104. Staff, A.C., Berge, L., Haugen, G., Lorentzen, B., Mikkelsen, B. and Henriksen, T. (2004)Diettary supplementation with L-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand 83: 103-107.
105. Steinert, J.R., Wyatt, A.W., Poston, L., Jacob, R. and Mann, G.E. (2002)Preeclampsia is associated with altered Ca2+ regulation and NO production in human fetal venous endothelial cells. FASEB J 16: 721-723.
106. Takata, M., Nakatsuka, M. and Kudo, T. (2002)Differential blood flow in uterine, ophthalmic, and brachial arteries of preeclamptic women. Obstet Gynecol 100: 931-939.
107. Taylor, D.J. and Lind, T. (1979)Red cell mass during and after normal pregnancy. Br J Obstet Gynaecol 86: 364-370.
108. Teran, E., Escudero, C. and Moya, W. (2006)Abnormal release of nitric oxide from nitrosoprotein in preeclampsia. Int J Gynaecol Obstet 92: 260-261.
109. Teran, E., Escudero, C., Vivero, S., Enriquez, A. and Calle, A. (2004)Intraplatelet cyclic guanosine-3',5'-monophosphate levels during pregnancy and preeclampsia. Hypertens Pregnancy 23: 303-308.
110. Toth, M. (2002)Role of tetrahydrobiopterin in the regulation of activity of human placental nitric oxide synthase in normal and pre-eclamptic pregnancies. Orv Hetil 143: 391-398.
111. Trogstad, L.I., Eskild, A., Bruu, A.L., Jeansson, S. and Jenum, P.A. (2001)Is preeclampsia an infectious disease ? Acta Obstet Gynecol Scand 80: 1036-1038.
112. Var, A., Yildirim, Y., Onur, E., Kuscu, N.K., Uyanik, B.S., Goktalay, K.et al. (2003)Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest 56: 221-224.
113. Venkatesha, S., Toporsian, M., Lam, C., Hanai, J., Mammoto, T., Kim, Y.M.et al. (2006)Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642-649.
114. Vural, P. (2002)Nitric oxide/endothelin-1 in preeclampsia. Clin Chim Acta 317: 65-70.
115. Walker, J.J. (2000)Pre-eclampsia. Lancet 356: 1260-1265.
116. Williams, D.J., Vallance, P.J., Neild, G.H., Spencer, J.A. and Imms, F.J. (1997)Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 272: H748-H752.
117. World Health Organization (2004) Maternal mortality in 2000: estimates developed by WHO, UNICEF and UNFPA.
118. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy (1988)Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 158: 80-83.
119. World Health Organization. (1987) Technical Reports Series. The hypertensive disorders of pregnancy, Geneve.
120. Xia, Y., Dawson, V.L., Dawson, T.M., Snyder, S.H.and Zweier J.L. (1996)Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitritemediated cellular injury. Proc Natl Acad Sci USA 93: 6770-6774.
121. Xia, Y., Wen, H., Bobst, S., Day, M.C. and Kellems, R.E. (2003)Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Investig 10: 82-93.
122. Xiang, W., Chen, H., Xu, X., Zhang, M. and Jiang, R. (2005)Expression of endothelial nitric oxide synthase traffic inducer in the placentas of women with pre-eclampsia. Int J Gynaecol Obstet 89: 103-107.
123. Yamamoto, T., Suzuki, Y., Kojima, K. and Suzumori, K. (2005)Reduced flow-mediated vasodilation is not due to a decrease in production of nitric oxide in preeclampsia. Am J Obstet Gynecol 192: 558-563.
124. Yanik, F.F., Amanvermez, R., Kocak, I., Yanik, A. and Celik, C. (2001)Serum nitric oxide and glutathione levels in preeclamptic and normotensive women during labor. Gynecol Obstet Invest 51: 110-115.
125. Yao, D., Vlessidis, A.G. and Evmiridis, N.P. (2004)Determination of nitric oxide in biological samples. Microchimica Acta 147: 1-20.
126. Yoneyama, Y., Suzuki, S., Sawa, R., Miura, A., Doi, D., Otsubo, Y.et al. (2002)Plasma nitric oxide levels and the expression of P-selectin on platelets in preeclampsia. Am J Obstet Gynecol 187: 676-680.
127. Yoshida, A., Nakao, S., Kobayashi, M. and Kobayashi, H. (2000)Flow-mediated vasodilation and plasma fibronectin levels in preeclampsia. Hypertension 36: 400-404.